His total treatment was five years – the last two of which he was, fortunately, in remission."

24 Apr 2025

Max’s ALL Journey

In June 2008 18-year-old Max England had just finished his A Levels and was looking forward to starting university in the autumn. But it was not to be, as Max started showing strange symptoms which eventually led to a diagnosis of leukaemia. 

“Max went away on a summer vacation with his friends,” said Max’s mum Ann, who now lives in Warsash, Hampshire. “Whilst he was away, he had symptoms of lethargy and one time he fainted. On return from the vacation his lethargy increased to the point he was almost constantly sleeping. Forty-eight hours after he came home we called the doctor. By this time Max was unable to walk to the surgery which was a few miles away and which he normally would have managed easily.” 

The family was living in Bakewell, Derbyshire at the time and Max was immediately sent by ambulance to Royal Hallamshire Hospital in Sheffield where he was given a blood test. Three days later doctors delivered the devastating news to Max and his family that he had acute lymphoblastic leukaemia (ALL). 

“We were so shocked and panicked. Would Max die? Would he live? We just didn’t know. We didn’t know anything much about leukaemia and what the future might hold. In short, we were terrified.” 

Max was kept for the first four weeks in an isolation ward and chemotherapy treatment started immediately.  

Max with Nan, Doreen

“Max’s health fluctuated during this time,” said Max’s dad Steve. “At one point he had a bad reaction to a combination of drugs which led him to have several mini strokes. This in turn led to him losing his speech, which was terrifying. He was on a drugs trial and we learnt that on one previous occasion someone else on the same trial had the same symptoms. The conflicting drugs were rectified and within 24 hours the problem was resolved.” 

Happily, during the last three years of his chemotherapy treatment, Max was at Oxford Brookes University studying for a degree in Planning which he achieved in 2013. Max is now 35 and living life to the full in Teddington, Middlesex, working in London as an estate agent and has regained his health enough to run two London Marathons. He got married in 2023 and he and his wife Katy are expecting their first child in April this year. 

“Strangely Max’s leukaemia was an enriching experience despite the challenges faced,” said Ann. “It made us a very close family unit who appreciated each other for who we are. We had major support from our family and our friends. We took inspiration from Max’s fortitude and the beautiful innocence of his friends from school. Their viewpoint throughout the whole situation was that Max would always be well and so it has proved to be.” 

Related posts

One Cancer Voice writes to Sajid Javid ahead of 10-Year Cancer Plan

1 August 2022

One Cancer Voice writes to Sajid Javid ahead of 10-Year Cancer Plan

Today, with over 50 cancer charities, we wrote to the Secretary of State for Health & Social Care, Sajid Javid, to set out our expectation for next month’s 10-Year Cancer Plan….

£200 grants for people affected by leukaemia once again available

4 April 2023

£200 grants for people affected by leukaemia once again available

Leukaemia UK and Leukaemia Care have this month relaunched the ‘Cost of Living Fund’, providing financial grants of £200 to patients with leukaemia, myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs),…

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

20 October 2023

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

Former Leukaemia UK John Goldman Fellows, Dr Matthew Blunt, University of Southampton and Dr Konstantinos Tzelepis, University of Cambridge have been recognised as ‘Emerging Leaders in Leukaemia’ by the major…

Leukaemia UK John Goldman Fellow awarded Professorship

28 November 2022

Leukaemia UK John Goldman Fellow awarded Professorship

Talented blood cancer researcher, Vignir Helgason, was awarded a Leukaemia UK John Goldman Fellowship in 2015, for his research into chronic myeloid leukaemia (CML). Since then, his research career has…